Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/25/2003EP1321465A2 A process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
06/25/2003EP1321461A1 N-(Cyclopropylmethyl)-azacycloalkanes, compositions containing them and methods for their preparation
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1321159A1 Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
06/25/2003EP1321151A1 Antiparkinsonism drugs
06/25/2003EP1321150A1 Pharmaceutical composition for treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
06/25/2003EP1321148A1 Cyclotetrasaccharide for augmenting "active-oxygen-eliminating-activity"
06/25/2003EP1321147A1 Orally administrable solid ribavirin dosage forms and process for making them
06/25/2003EP1321146A2 Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use
06/25/2003EP1321145A1 Antitumor agents
06/25/2003EP1321144A1 Eye drops
06/25/2003EP1321143A1 Combination of N-butyldeoxygalactonojirimycin and glycolipid degrading enzyme in therapy
06/25/2003EP1321142A1 Solid pharmaceutical composition for oral administration of Tegaserod
06/25/2003EP1321140A1 Ibuprofen solutions for capsule-filling and capsule prepartions
06/25/2003EP1321139A1 2-indanylamino derivatives for the therapy of chronic pain
06/25/2003EP1321138A1 Coenzyme Q10 for the treatment of ocular diseases
06/25/2003EP1320710A1 Drying method for selectively removing volatile components from wet coatings
06/25/2003EP1320623A1 Promoter sequences
06/25/2003EP1320597A2 Induction of exon skipping in eukaryotic cells
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320536A1 $g(a)-SUBSTITUTED $g(b)-AMINOETHYL PHOSPHONATES
06/25/2003EP1320533A1 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic
06/25/2003EP1320532A1 Tetrapyrroles
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
06/25/2003EP1320529A1 Quinoline derivatives as antibacterials
06/25/2003EP1320528A2 Substituted phthalides as anti-convulsive drugs
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320525A1 Antibacterial mutilins
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320385A1 Combination compositions
06/25/2003EP1320383A2 Photosensitisers
06/25/2003EP1320382A2 Novel methods for inhibition of viral infection
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320375A2 Inhibition of systemic infections in humans and vertebrates by dietary fibers
06/25/2003EP1320374A1 Influenza virus binding, sialylated oligosaccharide substance and use thereof
06/25/2003EP1320373A2 Treatment of arthritis and compositions therefore
06/25/2003EP1320372A1 Pharmaceutical preparation and method for treatment of diabetes
06/25/2003EP1320371A2 Charged phospholipid compositions and methods for their use
06/25/2003EP1320369A1 A method of analgesia
06/25/2003EP1320368A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage
06/25/2003EP1320367A1 Process for the preparation of dinapsoline
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP1320364A1 The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1320362A1 Stabilised fibrate microparticles
06/25/2003EP1320361A1 Method for reducing exacerbations associated with copd
06/25/2003EP1320359A2 Thermogelling biodegradable aqueous polymer solution
06/25/2003EP1320357A1 Topical polymeric antimicrobial emulsion
06/25/2003EP1320355A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
06/25/2003EP1320300A1 Food supplement
06/25/2003EP1283725A4 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
06/25/2003EP1283709A4 Peptide deformylase inhibitors
06/25/2003EP1263470B1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX
06/25/2003EP1250343B1 Azalide antibiotic compositions
06/25/2003EP1244650B1 Arylamine derivatives and their use as anti-telomerase agent
06/25/2003EP1221845B1 Active ingredient combinations having insecticidal and acaricidal properties
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/25/2003EP1200439B1 1,2-dihydro-1-oxo-parazino(1,2-a) indole derivatives
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1169313B1 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
06/25/2003EP1161436B1 Polyunsaturated fatty acid derivatives and their use in the treatment of cancer
06/25/2003EP1140110B1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP1135417B1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography
06/25/2003EP1112692B1 Drinks and foods capable of eliminating helicobacter pylori
06/25/2003EP1100800B1 Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors
06/25/2003EP1098896B1 5-bicycloindole compounds
06/25/2003EP1069915B1 Hydroxylation activated drug release
06/25/2003EP1064279B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003EP1019428B1 Inverted chimeric and hybrid oligonucleotides
06/25/2003EP1019036B1 Use of d-methionine to reduce the toxicity of ototoxic drugs and noise
06/25/2003EP1014927B1 Use of shogaols and gingerols for preparing deodorant compositions
06/25/2003EP1007006B1 Cefadroxil monohydrate tablet formulation
06/25/2003EP1001942B1 Polyhydroxybutylpyrazines, their preparation and medicines containing them
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0975342B1 Pharmaceutical formulations comprising amoxocyllin and clavulanate
06/25/2003EP0969737B1 Pet food composition
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
06/25/2003EP0932411B1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
06/25/2003EP0925064B1 5-ANDROSTENE 3 beta,17alpha DIOL AS AN INHIBITOR OF TUMOR GROWTH
06/25/2003EP0910365B1 Growth inhibition and eradication of solid tumors using a prolactin modulator and a photosensitizer
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0877807B1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0808172B1 Combination of angiotensin converting enzyme inhibitor and aldosterone antagonist for the treatment of ventricular hypertrophy
06/25/2003EP0806957B1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc together with azt.
06/25/2003EP0802783B1 Topical preparations containing l-arginine
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003EP0752862B1 Use of biopolymers for muscle treatment
06/25/2003EP0727984B1 Controlled release preparation
1 ... 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 ... 7860